
Salts and Derivatives of Active Pharmaceutical Ingredients (API)
The salts of Active Pharmaceutical Ingredients (APIs) are compounds formed by the reaction of an acid with a base, resulting in an ionic equilibrium. These salts often improve the solubility and stability of APIs, facilitating their absorption in the body. API derivatives are chemical variants of an active ingredient that may have enhanced or modified properties to optimise therapeutic efficacy. API salts are used in the formulation of oral, injectable, and topical medications. Additionally, API derivatives can improve the pharmacokinetics of drugs, such as enabling controlled release of active substances.
At CymitQuimica, we provide API salts and derivatives with the necessary purity and quality for research and pharmaceutical formulation development.
Found 79404 products of "Salts and Derivatives of Active Pharmaceutical Ingredients (API)"
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Risedronate Related Compound B ([3,6-Bis[(3-pyridinyl)methyl]-2,5-dihydroxy-2,5-dioxido-1,4,2,5-dioxadiphosphorinane-3,6-diyl]bis[phosphonic acid] disodium tetrahydrate salt)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C14H16N2O12P4Na2·4H2OColor and Shape:White Fine PowderMolecular weight:527.96537Dofetilide Related Compound A (N-[4-(2-{2-[4-(Methanesulfonamido)phenoxy]ethylamino}ethyl)phenyl]methanesulfonamide)
CAS:Sulfonamides, nesoiFormula:C18H25N3O5S2Color and Shape:White PowderMolecular weight:427.12356Amantadine Related Compound B (N-(Adamantan-1-yl)acetamide)
CAS:Cyclic amides and their derivatives, nesoiFormula:C12H19NOColor and Shape:White PowderMolecular weight:193.14666Palonosetron Related Compound A ((3aS)-1-Oxo-2-[(3S)-quinuclidin-3-yl]-2,3,3a,4,5,6-hexahydro-1H-benzo[de]isoquinoline 1-oxide)
CAS:Lactams not elsewhere specified or includedFormula:C19H24N2O2Color and Shape:White SolidMolecular weight:312.18378Azathioprine Related Compound G (6-[(1-methyl-4-nitro-1H-imidazol-5-yl)thio]-9H-purin-2-amine)
CAS:Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, nesoiFormula:C9H8N8O2SColor and Shape:PowderMolecular weight:292.04909Ticlopidine Related Compound B (5-(2-chlorobenzyl)-4-oxo-4,5,6,7-tetrahydrothieno-[3,2-c]pyridine)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C14H12ClNOSColor and Shape:White PowderMolecular weight:277.03281Bendamustine Related Compound C (Ethyl 4-{5-[bis(2-hydroxyethyl)amino]-1-methyl-1H -benzimidazol-2-yl}butanoate)
CAS:Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFormula:C18H27N3O4Color and Shape:White PowderMolecular weight:349.20016Triclocarban Related Compound A (1,3-Bis(4-chlorophenyl)urea)
CAS:Ureines and their derivatives; salts thereofFormula:C13H10Cl2N2OColor and Shape:White Off-White PowderMolecular weight:280.01702Captopril Disulfide
CAS:Heterocyclic compounds (excluding aromatic or modified aromatic) withnitrogen hetero-atom(s) only nesoiFormula:C18H28N2O6S2Color and Shape:White Solid Crystalline PowderMolecular weight:432.13888Desoximetasone Related Compound A (9-Fluoro-11β,21-dihydroxy-16α-methylpregna-4-ene-3,20-dione)
CAS:Halogenated derivatives of adrenal cortical hormonesFormula:C22H31FO4Color and Shape:Off-White Beige SolidMolecular weight:378.22064Lufenuron Related Compound C (N-[3-Chloro-4-(1,1,2,3,3,3-hexafluoropropoxy)phenylcarbamoyl]-2,6-difluorobenzamide)
CAS:Ureines and their derivatives; salts thereofFormula:C17H9ClF8N2O3Color and Shape:SolidMolecular weight:476.0174Trisalicylic Acid
CAS:Esters of salicylic acid and its salts not elsewhere specified or includedFormula:C21H14O7Color and Shape:White PowderMolecular weight:378.07395Fluphenazine Related Compound A (10-{3-[4-(2-Hydroxyethyl)piperazin-1-yl]propyl}-2-(trifluoromethyl)-10H-phenothiazine 5-oxide)
CAS:Compounds (excluding drugs) containing a phenothiazine ring-system (whether or not hydrogenated), not further fusedFormula:C22H26F3N3O2SColor and Shape:Off-White Light Orange SolidMolecular weight:453.16978Diphenhydramine N-Oxide (2-(benzhydryloxy)-N,N-dimethylethan-1-amine oxide hydrochloride)
CAS:Amino-alcohols, other than those containing more than one kind of oxygen function, their ethers and esters, salts thereof, nesoiFormula:C17H21NO2·HClColor and Shape:PowderMolecular weight:307.13391Ketorolac Related Compound B (5-benzoyl-2,3-dihydro-1H-pyrrolizin-1-ol)
CAS:Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFormula:C14H13NO2Color and Shape:Yellow SolidMolecular weight:227.09463Oxaliplatin Related Compound D (cis-[(1S,2S)-1,2-cyclohexanediamine-N,N'][oxalato(2-)-O,O']platinum)
CAS:Inorganic or organic compounds of precious metals, whether or not chemically defined, or amalgams of precious metals, nesoiFormula:C8H14N2O4PtColor and Shape:White Off-White Crystalline PowderMolecular weight:397.06015Carmustine Related Compound A (1,3-bis(2-chloroethyl)urea)
CAS:Acyclic amides (including acyclic carbamates) and their derivatives and salts thereof, nesoiFormula:C5H10Cl2N2OColor and Shape:White PowderMolecular weight:184.01702


